Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nomura Holdings Inc (NMR) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

Nomura Holdings IncTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

Nomura Holdings Inc vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Nomura Holdings Inc trades at $9.2 (market cap $28.01B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Nomura Holdings Inc is far larger — about 2.6× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Nomura Holdings Inc pays the higher dividend (3.38%). Which is the better fit depends on your goals — on Pluang, investors hold Nomura Holdings Inc for 56 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

NMRRDY
Market Cap
$28.01B$10.78B
Volume
686,8012,724,343
Sector
FinancialsHealth
52-Week High
$10.86$15.38
52-Week Low
$6.92$11.38
Typical Hold Time
56 Days0 Days
Enterprise Value
$38.48T$10.68B
Dividend Yield
3.38%0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nomura Holdings Inc

Nomura Holdings (NMR) trades at $9.26, down 3.24% with bearish technical signals. The stock shows mixed earnings performance with recent misses but strong revenue growth from $1.66T in 2025. Valuation appears attractive with P/E of 11.37 and P/B of 1.16, while analyst sentiment leans cautious with 67% hold ratings. Recent Zacks coverage highlights momentum potential and hammer chart pattern formation.

Outlook remains balanced with fundamental strength in profitability margins (20.4% net income) offset by technical weakness. Investment opportunity lies in discounted valuation amid earnings growth, while risks include cash flow volatility and rising debt levels. The stock requires careful monitoring of Q3 2026 earnings results for directional clarity.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NMR
77% Buy23% Sell
Avg holding period · 56 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

About Nomura Holdings Inc

Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.

Read more on NMR →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →